BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel SK, Valicherla GR, Micklo AC, Rohan LC. Drug delivery strategies for management of women's health issues in the upper genital tract. Adv Drug Deliv Rev 2021;177:113955. [PMID: 34481034 DOI: 10.1016/j.addr.2021.113955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Teworte S, Luciani P. Endometriosis, the Silent Disease: Molecular Targets, Active Principles, and Drug Delivery Systems. Helvetica Chimica Acta 2022. [DOI: 10.1002/hlca.202200132] [Reference Citation Analysis]
2 Fanse S, Bao Q, Burgess DJ. Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities. Adv Drug Deliv Rev 2022;191:114581. [PMID: 36270490 DOI: 10.1016/j.addr.2022.114581] [Reference Citation Analysis]
3 Li B, Zhang L, Xie Y, Lei L, Qu W, Sui L. Evaluation of pharmacokinetics and safety of a long-term estradiol-releasing stent in rat uterine. Regen Ther 2022;21:494-501. [PMID: 36313395 DOI: 10.1016/j.reth.2022.10.001] [Reference Citation Analysis]
4 Da L, Sun Y, Lin Y, Chen S, Chen G, Zheng B, Du S. Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues. Pharmaceutics 2022;14:1718. [DOI: 10.3390/pharmaceutics14081718] [Reference Citation Analysis]
5 das Neves J, Ensign L. Advances in drug delivery for women's health: A matter of gender equity. Adv Drug Deliv Rev 2022;182:114132. [PMID: 35090956 DOI: 10.1016/j.addr.2022.114132] [Reference Citation Analysis]